Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.038 | 0.4 |
mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.051 | 0.4 |
mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.034 | 0.4 |
mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.4 |
mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.4 |